VACCINATION IN RHEUMATIC DISEASES: AN ALLY OR AN ENEMY?
https://doi.org/10.14412/1995-4484-2018-401-404
Abstract
The importance of comorbid infections in rheumatology has recently increased substantially, particularly due to the introduction of biological agents into clinical practice. One of the ways to solve the above problem is to investigate and actively use different vaccines. The paper deals with the issues concerning the use of vaccines against influenza and pneumococcal infections in rheumatic patients. It discusses the safety and immunogenicity of vaccination in preventing respiratory infections as the most common cause of an adverse outcome in rheumatic diseases. Main areas for future investigations of the considered problem are shown.
About the Author
B. S. Belov
V.A. Nasonova Research Institute of Rheumatology, Moscow
Russian Federation
Russian Federation
References
1. Tektonidou MG, Lewandowski LB, Hu J, et al. Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis. 2017 Dec;76(12):2009-16.
2. doi: 10.1136/annrheumdis-2017-211663
3. Polyanskaya MV. Pnevmoniya u pacientov s revmaticheskimi zabolevaniyami: chastota vstrechaemosti, klinicheskaya kartina, faktory riska: Avtoref. dis. … kand. med. nauk [Pneumonia in patients with rheumatic diseases: frequency of occurrence, clinical picture, risk factors: Author's abstract. Dis. ... Cand. Med. Sci]. Moscow; 2009. 24 p. (In Russ.)
4. Van Assen S, Agmon-Levin N, Elkayam O, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2011;70(3):414-22. doi: 10.1136/ard.2010.137216
5. Singh JA, Saag KG, Bridges SL, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheum. 2016;68(1):1-26. doi: 10.1002/art.39480
6. Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):e44-100. doi: 10.1093/cid/cit684
7. Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis. 2014;73(1):62-8.
8. doi: 10.1136/annrheumdis-2013-204223
9. Luque Ramos A, Hoffmann F, Callhoff J, et al. Influenza and pneumococcal vaccination in patients with rheumatoid arthritis in comparison with age- and sex-matched controls: results of a claims data analysis. Rheumatol Int. 2016;36(9):1255-63.
10. doi: 10.1007/s00296-016-3516-1
11. Friedman MA, Winthrop K. Vaccinations for rheumatoid arthritis. Curr Opin Rheumatol. 2016 May;28(3):330-6.
12. doi: 10.1097/BOR.0000000000000281
13. Rakoczi E, Szekanecz Z. Pneumococcal vaccination in autoimmune rheumatic diseases. RMD Open. 2017 Sep 14;3(2):e000484/ doi: 10.1136/rmdopen-2017-000484
14. Meroni PL, Zavaglia D, Girmenia С. Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugs. Clin Exp Rheumatol. 2018 Mar-Apr;36(2):317-28.
15. Subesinghe S, Bechman K, Rutherford AI, et al. A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis. J Rheumatol. 2018 Jun;45(6):733-44. doi: 10.3899/jrheum.170710
16. Bengtsson C, Kapetanovic MC, Kä llberg H, et al. Common vaccinations among adults do not increase the risk of developingrheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis. 2010;69(10):1831-3. doi: 10.1136/ard.2010.129908
17. Naumtseva MS, Belov BS, Aleksandrova EN, et al. Immunogenicity and safety of 23-valent polysaccharide pneumococcal vaccine in patients with rheumatoid arthritis: Results of a two-year follow-up study. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016;54(6):674-80 (In Russ.)]. doi: 10.14412/1995-4484-2016-674-680
18. Belov BS, Sergeeva MS, Tarasova GM, Buhanova DV. Vaccination in rheumatology: the evolution of views on the problem. Terapevticheskij Arhiv. 2017;89(5):83-9 (In Russ.)
19. Buhanova DV, Belov BS. Vaccination against influenza in patients with rheumatic diseases. In: XV nauchno-prakticheskaya konferenciya «Problemy sovremennoj revmatologii». Sbornik nauchnyh trudov [XV scientific-practical conference «Problems of modern rheumatology». Collection of scientific papers]. Moscow: InfoMedFarm Dialog; 2018. P. 28-34 (In Russ.)
20. Tarasova GM, Belov BS, Buhanova DV, et al. Investigation of immunogenicity and safety of 23-valent polysaccharide pneumococcal vaccine in patients with systemic lupus erythematosus. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2018;56(4):433-438 (In Russ.)
21. Bijl M, Agmon-Levin N, Dayer JM, et al. Vaccination of patients with autoimmune inflammatory rheumatic diseases requires careful benefit-risk assessment. Autoimmun Rev. 2012 Jun;11(8):572-6. doi: 10.1016/j.autrev.2011
22. Kapetanovic MC, Saxne T, Sjö holm A, et al. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford). 2006 Jan;45(1):106-11. doi: 10.1093/rheumatology/kei193
Review
For citations:
Belov B.S. VACCINATION IN RHEUMATIC DISEASES: AN ALLY OR AN ENEMY? Rheumatology Science and Practice. 2018;56(4):401-404. (In Russ.) https://doi.org/10.14412/1995-4484-2018-401-404
Views:
83911
Email this article 